Target
Free fatty acid receptor 1
Ligand
BDBM294024
Substrate
n/a
Meas. Tech.
In Vitro Assay GPR40 Calcium Flux Assay
Temperature
298.15±n/a K
EC50
54.0±n/a nM
Comments
extracted
Citation
 Meegalla, SPlayer, MRHuang, HWinters, MP Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes US Patent  US10106553 Publication Date 10/23/2018 
Target
Name:
Free fatty acid receptor 1
Synonyms:
FFAR1 | FFAR1_HUMAN | G-protein Coupled Receptor 40 | GPR40
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
31473.32
Organism:
Homo sapiens (Human)
Description:
O14842
Residue:
300
Sequence:
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK
  
Inhibitor
Name:
BDBM294024
Synonyms:
(2S)-5-(2-(4-((3- Cyclopentylbenzo[b]thiophen- 5-yl)methoxy)phenyl)pent-3-yn- 1-yl)-1H-tetrazole | US10106553, Compound 56
Type:
Small organic molecule
Emp. Form.:
C26H26N4OS
Mol. Mass.:
442.576
SMILES:
CC#C[C@@H](Cc1nnn[nH]1)c1ccc(OCc2ccc3scc(C4CCCC4)c3c2)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: